Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13641888 | 0.90 | THRB (0.41) | THRBTAAR1AOC3ADRA2AADRA2C | |
| SCHEMBL13403919 | 0.90 | THRB (0.41) | THRBTAAR1AOC3ADRA2AADRA2C | |
| Ether SCHEMBL8937056 | 0.89 | TAAR1 (0.41) | THRBTAAR1AOC3LMNAALDH1A1 | |
| SCHEMBL9619659 | 0.86 | LMNA (0.43) | THRBTAAR1AOC3ADRA2AADRA2C | |
| SCHEMBL7929659 | 0.85 | THRB (0.41) | THRBTAAR1AOC3ADRA2AADRA2C | |
| SCHEMBL1157986 | 0.84 | THRB (0.44) | THRBTAAR1AOC3ADRA2AADRA2C | |
| SCHEMBL12884228 | 0.82 | THRB (0.57) | THRBTAAR1AOC3ADRA2AADRA2C | |
| SCHEMBL15113559 | 0.82 | THRB (0.57) | THRBTAAR1AOC3ADRA2AADRA2C | |
| SCHEMBL9911361 | 0.82 | THRB (0.57) | THRBTAAR1AOC3ADRA2AADRA2C | |
| SCHEMBL7553120 | 0.80 | THRB (0.41) | THRBTAAR1ADRA2AADRA2CCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514624-A | N-monofluoromethyl carbonyl compound and preparation method thereof | 中山大学附属第一医院 | 2023-08-01 | — | — | CN | claimed |
| US-20040059165-A1 | Synthesis of aliphatic 1,3-diols utilizing reduced ligand concentration and water extraction | POWELL JOSEPH BROUN (US) | 2004-03-25 | — | — | US | claimed |
| US-6660892-B2 | Catalytic hydroformylation, hydrogenation of oxirane | SHELL OIL COMPANY | 2003-12-09 | — | — | US | claimed |
| US-20030166977-A1 | Synthesis of aliphatic 1, 3-diols utilizing reduced ligand concentration and water extraction | SHELL OIL COMPANY | 2003-09-04 | — | — | US | claimed |
| CN-116514624-B | N-monofluoromethyl carbonyl compound and preparation method thereof | 中山大学附属第一医院 | 2024-07-23 | — | — | CN | disclosed |
| CN-116514624-A | N-monofluoromethyl carbonyl compound and preparation method thereof | 中山大学附属第一医院 | 2023-08-01 | — | — | CN | disclosed |
| CN-111051470-B | Process for preparing liquid composition | 住友化学株式会社 | 2020-11-10 | — | — | CN | disclosed |
| CN-107532017-B | Stripping solvent composition, stripping method and cleaning solvent composition | 日本瑞翁株式会社 | 2020-11-06 | — | — | CN | disclosed |
| CN-111051470-A | Process for preparing liquid composition | 住友化学株式会社 | 2020-04-21 | — | — | CN | disclosed |
| EP-3296366-B1 | RELEASE SOLVENT COMPOSITION, RELEASE METHOD, AND CLEANING SOLVENT COMPOSITION | ZEON CORP (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20180141090-A1 | RELEASE SOLVENT COMPOSITION, RELEASE METHOD, AND CLEANING SOLVENT COMPOSITION | ZEON CORPORATION (JP) | 2018-05-24 | — | — | US | disclosed |
| EP-3296366-A1 | RELEASE SOLVENT COMPOSITION, RELEASE METHOD, AND CLEANING SOLVENT COMPOSITION | Zeon Corporation (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-5447901-A | Color-developing sheet: base material coated with composition of /a/ multivalent metal-modified salicylic acid resin formed from salicylic acid, a benzyl compound and optional styrene and /b/ analogous resin free of salicylic acid | MITSUI TOATSU CHEMICAL, INC. (JP) | 1995-09-05 | — | — | US | disclosed |
| US-5376615-A | Pressure sensitive elements containing a salicylic acid resin and a phenolic resin | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1994-12-27 | — | — | US | disclosed |
| EP-0523697-A1 | Color-developing compositions and their use | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-01-20 | — | — | EP | disclosed |
| CN-1016432-B | Salicylic acid copolymer and method for preparing metal salt thereof | MITSUI TOATSU CHEMICAIS INC (JP) | 1992-04-29 | — | — | CN | disclosed |
| US-5023366-A | Reacted with a benzyl halide, alcohol or ether; for pressure sensitive elements | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1991-06-11 | — | — | US | disclosed |
| CN-1051368-A | Salicylic acid copolymers and its metal-salt and preparation method thereof contain the developer of this metal salts of copolymers and the colour developing paper of this developer of employing | MITSUI TOATSU CHEMICALS (JP) | 1991-05-15 | — | — | CN | disclosed |
| CN-87107802-A | Salicylic acid copolymer and metal salt thereof, process for producing the same, color-developing agent containing the copolymer metal salt, and color-developing paper using the color-developing agent | — | 1988-08-10 | — | — | CN | disclosed |
| EP-0268878-A2 | Salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal salts of the copolymers and color-developing sheets employing the agents | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1988-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166977-A1 | Synthesis of aliphatic 1, 3-diols utilizing reduced ligand concentration and water extraction | OXGR1, OXER1, ADH1A | THRB 3057/4885TAAR1 545/4885AOC3 22/4885 |
| US-20040059165-A1 | Synthesis of aliphatic 1,3-diols utilizing reduced ligand concentration and water extraction | OXGR1, OXER1, ADH1A | THRB 3057/4885TAAR1 545/4885AOC3 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.